This tool allows the users to submit methylation beta values of CpG sites (Probe IDs associated with CpG sites) and predict the cancer status using methylation data of signature CpG sites, resulting from analysis of CpG site associated methylation array data of Liver Hepatocellular Carcinoma from TCGA dataset from GDC Data portal . This method requires methylation beta values of CpG sites in each patient to predict cancer status whether subject is in Stage-I or late stage of LIHC. The first column is CpG sites and in second column methylatin level of corresponding CpG sites in terms of methylation beta value in a particular number of patients. For more information please click . |